Human

Human Prostate Gene DataBase

Name nuclear receptor coactivator 3
Symbol NCOA3
Aliases ACTR; AIB1; RAC3; CTG26; P/CIP; CAGH16; TNRC14; TNRC16; TRAM-1; Amplified in breast cancer-1
Gene Product
  • nuclear receptor coactivator 3
Category
  • Polymorphism in Prostate cancer
UniGeneHs.225977
OMIM601937
Locus8202
SummaryMember of the SRC-1 family of transcriptional coactivators
Gene Ontology
Expression
EST (310 ESTs, 151 libraries)
Tissue ? Frequency ? Count ?
adipose (1/10)0.047 1/2445
b cells (1/1)0.002 1/16734
blood (1/27)0.008 3/40686
bone (1/13)0.003 1/26211
bone marrow (4/263)0.291 7/38555
brain (7/204)0.003 8/362011
cervix (2/7)0.015 4/28115
colon (5/853)0.036 9/165626
connective tissue (1/1)0.022 1/1301
ear (1/2)0.005 2/12660
embryo (2/19)0.001 2/37976
eye (3/33)0.004 4/93836
germ cell (1/7)0.013 1/57383
head and neck (7/990)0.089 7/79796
heart (4/22)0.043 7/55494
kidney (5/86)0.004 11/132968
liver (1/38)0.002 1/46472
lung (9/312)0.019 16/245386
muscle (3/21)0.006 10/71297
nervous (4/475)0.488 4/43438
oral cavity (1/18)0.006 9/44567
ovary (3/144)0.339 5/81880
pancreas (5/33)0.001 7/117255
placenta (13/342)0.514 44/157762
prostate (6/291)0.004 9/109871
skin (1/31)0.053 1/100815
stomach (9/312)0.046 16/129930
testis (4/171)1.000 9/117531
thymus (1/17)0.036 1/5021
thyroid (1/24)0.016 1/6853
uncharacterized tissue (36/1773)0.004 77/713325
uterus (5/212)0.006 14/155110
SAGE (19118681 tags, 348 libraries)
Tissue ? Frequency ? Count ?
brain (19/19)0.029 84/4191374
cerebellum (1/1)0.019 4/153840
colon (8/8)0.053 52/2527110
eye (4/6)0.030 25/1642626
heart (1/1)0.066 13/759213
kidney (2/2)0.010 2/73935
liver (1/1)0.012 1/66861
lung (1/1)0.009 3/267429
mammary gland (15/19)0.069 84/1642381
muscle (2/2)1.000 503/592471
ovary (10/10)0.079 34/912289
pancreas (7/8)0.025 16/594524
prostate (10/13)0.032 42/1765700
skin (2/7)0.049 3/43151
stomach (3/3)0.027 12/662496
uncharacterized tissue (18/22)0.052 92/2728346
vascular (3/3)0.024 12/494935
SNPrs2780389 (G/A:intron);  rs2076546 (T/C:intron);  rs2664555 (G/A:coding-nonsyn);  rs427967 (A/G:intron);  rs864338 (C/T:intron);  rs1474731 (A/G:intron);  rs642417 (A/G:intron);  rs3092417 (A/G:mrna-utr);  rs401352 (G/A:intron);  rs378890 (T/C:intron);  rs3092324 (-/AT:mrna-utr);  rs627601 (A/G:intron);  rs366442 (T/A:intron);  rs3092309 (C/-:intron);  rs2745724 (G/A:intron);  rs396221 (A/C:intron);  rs2273022 (C/G:intron);  rs365602 (C/T:intron);  rs434258 (C/T:intron);  rs720500 (A/G:intron);  rs1801981 (T/G:mrna-utr);  rs2267962 (C/T:intron);  rs2664536 (C/G:mrna-utr);  rs2664522 (A/G:coding-nonsyn);  rs12273 (G/A:mrna-utr);  rs852256 (A/G:intron);  rs14189 (A/T:mrna-utr);  rs1052765 (G/A:coding-nonsyn);  rs623953 (A/G:intron);  rs387249 (G/T:intron);  rs2664573 (G/A:intron);  rs2256720 (T/C:intron);  rs2179590 (A/G:locus-region);  rs2230781 (A/G:coding-nonsyn);  
EvidencePolymorphism in Prostate cancer

© 2002, PGDB, All Rights Reserved.
Department of Urology
Universityof California, San Francisco